RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28956771http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28956771http://www.w3.org/2000/01/rdf-schema#comment"Activation of innate immunity is essential for host cells to restrict the spread of invading viruses and other pathogens. However, attenuation or termination of signaling is also necessary for preventing immune-mediated tissue damage and spontaneous autoimmunity. Here, we identify nucleotide binding oligomerization domain (NOD)-like receptor X1 (NLRX1) as a negative regulator of the mitochondrial antiviral signaling protein (MAVS)-mediated signaling pathway during hepatitis C virus (HCV) infection. The depletion of NLRX1 enhances the HCV-triggered activation of interferon (IFN) signaling and causes the suppression of HCV propagation in hepatocytes. NLRX1, a HCV-inducible protein, interacts with MAVS and mediates the K48-linked polyubiquitination and subsequent degradation of MAVS via the proteasomal pathway. Moreover, poly(rC) binding protein 2 (PCBP2) interacts with NLRX1 to participate in the NLRX1-induced degradation of MAVS and the inhibition of antiviral responses during HCV infection. Mutagenic analyses further revealed that the NOD of NLRX1 is essential for NLRX1 to interact with PCBP2 and subsequently induce MAVS degradation. Our study unlocks a key mechanism of the fine-tuning of innate immunity by which NLRX1 restrains the retinoic acid-inducible gene I-like receptor (RLR)-MAVS signaling cascade by recruiting PCBP2 to MAVS for inducing MAVS degradation through the proteasomal pathway. NLRX1, a negative regulator of innate immunity, is a pivotal host factor for HCV to establish persistent infection.IMPORTANCE Innate immunity needs to be tightly regulated to maximize the antiviral response and minimize immune-mediated pathology, but the underlying mechanisms are poorly understood. In this study, we report that NLRX1 is a proviral host factor for HCV infection and functions as a negative regulator of the HCV-triggered innate immune response. NLRX1 recruits PCBP2 to MAVS and induces the K48-linked polyubiquitination and degradation of MAVS, leading to the negative regulation of the IFN signaling pathway and promoting HCV infection. Overall, this study provides intriguing insights into how innate immunity is regulated during viral infection."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.org/dc/terms/identifier"doi:10.1128/jvi.01264-17"xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Guo M."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Liu C."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Li G."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Tian R."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Wang X."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Zhu H."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Yang D."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Xie Q."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Xue B."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/author"Qin Y."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/name"J Virol"xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/pages"e01264-17"xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/title"NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2."xsd:string
http://purl.uniprot.org/citations/28956771http://purl.uniprot.org/core/volume"91"xsd:string
http://purl.uniprot.org/citations/28956771http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28956771
http://purl.uniprot.org/citations/28956771http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28956771
http://purl.uniprot.org/uniprot/#_A0A9L9PX86-mappedCitation-28956771http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28956771
http://purl.uniprot.org/uniprot/#_A0A384N6B9-mappedCitation-28956771http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28956771
http://purl.uniprot.org/uniprot/#_B4DRD7-mappedCitation-28956771http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28956771
http://purl.uniprot.org/uniprot/#_B7Z889-mappedCitation-28956771http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28956771
http://purl.uniprot.org/uniprot/#_Q15366-mappedCitation-28956771http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28956771